The drug reduces insulin resistance and blood glucose levels through inhibition of mitochondrial respiratory chain complex 1 leading to reduced ATP production and subsequently provoking AMPK activation and mTOR inhibition [72, 73]. Here, MTOR is linked to Insulin resistance.